AU2002329970A1 - Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase - Google Patents

Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase

Info

Publication number
AU2002329970A1
AU2002329970A1 AU2002329970A AU2002329970A AU2002329970A1 AU 2002329970 A1 AU2002329970 A1 AU 2002329970A1 AU 2002329970 A AU2002329970 A AU 2002329970A AU 2002329970 A AU2002329970 A AU 2002329970A AU 2002329970 A1 AU2002329970 A1 AU 2002329970A1
Authority
AU
Australia
Prior art keywords
rna
pyrimidines
pyrrolo
viral polymerase
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002329970A
Inventor
Sanjib Bera
Balkrishen Bhat
Steven S. Carroll
Anne Bettina Eldrup
Lawrence C. Kuo
Malcolm Maccoss
Leila Malik
David B. Olsen
Marija Prhavc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Ionis Pharmaceuticals Inc
Original Assignee
Merck and Co Inc
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc, Isis Pharmaceuticals Inc filed Critical Merck and Co Inc
Publication of AU2002329970A1 publication Critical patent/AU2002329970A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002329970A 2001-09-04 2002-08-29 Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase Abandoned AU2002329970A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31707001P 2001-09-04 2001-09-04
US60/317,070 2001-09-04
PCT/US2002/028078 WO2003020222A2 (en) 2001-09-04 2002-08-29 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE

Publications (1)

Publication Number Publication Date
AU2002329970A1 true AU2002329970A1 (en) 2003-03-18

Family

ID=23231976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002329970A Abandoned AU2002329970A1 (en) 2001-09-04 2002-08-29 Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase

Country Status (2)

Country Link
AU (1) AU2002329970A1 (en)
WO (1) WO2003020222A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103304541A (en) 2004-02-20 2013-09-18 贝林格尔.英格海姆国际有限公司 Viral polymerase inhibitors
CN107743491B (en) 2015-05-08 2020-08-21 豪夫迈·罗氏有限公司 Novel oxathiolanecarboxylic acids and derivatives thereof for the treatment and prevention of viral infections
EA201890454A1 (en) 2015-08-06 2018-07-31 Чимерикс, Инк. PYRROPHYRIMIDINE NUCLEOSIDE AND THEIR ANALOGUES THAT CAN BE USED AS ANTI-VIRUS MEANS
EP3684771A1 (en) 2017-09-21 2020-07-29 Chimerix, Inc. MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF
WO2019143977A1 (en) * 2018-01-18 2019-07-25 Array Biopharma Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration

Also Published As

Publication number Publication date
WO2003020222A3 (en) 2003-11-27
WO2003020222A2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
HUS2200038I1 (en) Hiv inhibiting pyrimidine derivatives
AU2002327168A1 (en) Pyrrolo(2,3-d)pyrimidine nucleoside analogs
AU2001272258A1 (en) Viral polymerase inhibitors
IL222761A0 (en) Viral polymerase inhibitors
HK1062300A1 (en) 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d)pyrimidine derivatives
SI1235830T1 (en) PYRROLO(2,3-d)PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
AU2002317910A1 (en) Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
AU2003292007A1 (en) 4-AMINO-5-PHENYL-7-CYCLOHEXYL-PYRROLO(2,3-d)PYRIMIDINE DERIVATIVES
EP1383769A4 (en) 6-substituted pyrazolo 3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
AU2002353164A1 (en) Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
AU2002362806A1 (en) Pyrimidine derivatives
AU2002257446A1 (en) Antiviral nucleosides
AU2002365211A1 (en) 6-substituted pyrazolo (3,4-d) pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
AU2002329970A1 (en) Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
EP1399541A4 (en) N4 virion single-stranded dna dependent rna polymerase
AU2002216033A1 (en) Use of pyrazolo(4,3-d)pyrimidines
AU2002354843A1 (en) Viral polymerase inhibitors
WO2005016878A3 (en) METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
AU2002315992A1 (en) New pyrazolo(3,4-d)pyrimidines inhibiting h. pylori infections
AU2002241194A1 (en) Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
AUPR520201A0 (en) Antiviral compounds
AU2002257892A1 (en) Compounds inhibiting cyclic nucleotide phosphodiesterases, preparation and uses thereof
GB0130520D0 (en) RNA polymerase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase